Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing-Reference-Cited by-同舟云学术

Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing

Published:2019-08 Issue: Volume:36 Page:40-47
ISSN:1047-2797
Container-title:Annals of Epidemiology
language:en
Short-container-title:Annals of Epidemiology

Author:

Fokom Domgue Joël,Cunningham Sonia A.,Yu Robert K.,Shete Sanjay

Funder

Cancer Prevention and Research Institute of Texas

National Cancer Institute

Publisher

Elsevier BV

Subject

Epidemiology

Reference42 articles.

1. U.S. Cancer Statistics Data Visualizations Tool, based on November 2018 submission data (1999–2016),2019

2. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey;Watson;Prev Med,2017

3. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

4. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017 (vol 67, pg 909, 2018);Walker;MMWR Morb Mortal Wkly Rep,2018

5. HPV-FASTER: broadening the scope for prevention of HPV-related cancer;Bosch;Nat Rev Clin Oncol,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Politicisation of Science and Health Topics;Palgrave Handbook of Science and Health Journalism;2024

2. Predictive value of hepatitis B serological indicators for mortality among cancer survivors and validation in a gastric cancer cohort;PLOS ONE;2023-12-27

3. Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications;Cancers;2023-07-20

4. Attitudes towards prevention of cervical cancer and early diagnosis among female academicians;Journal of Obstetrics and Gynaecology Research;2022-03-09

5. Prognostic impact of hepatitis B virus infection in patients with primary cervical cancer;Cancer Medicine;2021-10-21